UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q4 2022 | 2022-11-15 | Future report Set alerts | |
| Q3 2022 | 2022-08-04 | 0.43 | 0.43 |
| Q2 2022 | 2022-05-05 | 0.18 | 0.18 |
| Q1 2022 | 2022-02-03 | 0.08 | 0.08 |
| Q4 2021 | 2021-11-17 | 0.38 | 0.38 |
| Q3 2021 | 2021-08-05 | 0.44 | 0.44 |
| Q2 2021 | 2021-05-06 | 0.26 | 0.26 |
| Q1 2021 | 2021-02-04 | 0.12 | 0.12 |
| Q4 2020 | 2020-11-18 | 0.37 | 0.00 |
| Q3 2020 | 2020-08-05 | 0.42 | -0.02 |
| 2016-06-10 | Reiterated Rating | Morgan Stanley | Hold | |
| 2016-06-06 | Reiterated Rating | B. Riley | Buy | $8.00 |
| 2016-06-04 | Reiterated Rating | Credit Suisse | Buy | |
| 2016-06-04 | Reiterated Rating | Deutsche Bank | Hold | |
| 2016-06-04 | Reiterated Rating | Credit Suisse Group AG | Buy | |
| 2016-06-04 | Reiterated Rating | Deutsche Bank AG | Hold | |
| 2016-06-01 | Reiterated Rating | B. Riley | Buy | $8.00 |
| 2016-04-12 | Reiterated Rating | B. Riley | Buy | $8.00 |
| 2016-04-07 | Reiterated Rating | B. Riley | Buy | $8.00 |
| 2016-03-06 | Reiterated Rating | B. Riley | Buy | $8.00 |
| 2016-03-02 | Reiterated Rating | Needham & Company LLC | Buy | $9.00 to $7.00 |
| 2016-03-02 | Lower Price Target | Credit Suisse | Outperform | $9.00 to $5.00 |
| 2016-03-01 | Reiterated Rating | B. Riley | Buy | $8.00 |
| 2016-02-25 | Reiterated Rating | B. Riley | Buy | $8.00 |
| 2015-12-06 | Reiterated Rating | Deutsche Bank | Hold | $6.00 |
| 2015-12-06 | Reiterated Rating | B. Riley | Buy | $8.00 |
| 2015-12-03 | Lower Price Target | Northland Securities | Outperform | $9.00 to $6.00 |
| 2015-12-01 | Reiterated Rating | Needham & Company LLC | Buy | $9.00 |
| 2015-12-01 | Reiterated Rating | B. Riley | Buy | $8.50 |
| 2015-09-06 | Reiterated Rating | B. Riley | Buy | $8.50 |
| 2015-09-02 | Downgrade | Morgan Stanley | Overweight to Equal Weight | $9.00 to $6.00 |
| 2015-09-01 | Lower Price Target | Deutsche Bank | Hold | $10.00 to $6.00 |
| 2015-09-01 | Reiterated Rating | Needham & Company LLC | Buy | $9.00 |
| 2015-08-31 | Reiterated Rating | B. Riley | Buy | $4.50 |
| 2015-08-26 | Reiterated Rating | B. Riley | Buy | $4.50 |
| 2015-06-12 | Reiterated Rating | Needham & Company LLC | Buy | $9.00 |
| 2015-06-12 | Reiterated Rating | B. Riley | Buy | $8.50 |
| 2015-06-11 | Lower Price Target | Credit Suisse | Outperform | $10.00 to $9.00 |
| 2015-06-05 | Upgrade | B. Riley | Neutral to Buy | $8.50 |
| 2015-06-04 | Reiterated Rating | Deutsche Bank | Hold | $10.00 |
| 2015-05-29 | Initiated Coverage | Needham & Company LLC | Buy | $9.00 |
| 2015-03-11 | Downgrade | B. Riley | Neutral | $8.50 |
| 2015-03-09 | Initiated Coverage | Northland Securities | Outperform | |
| 2015-03-04 | Downgrade | B. Riley | Buy to Neutral | $8.50 |
| 2015-03-04 | Lower Price Target | Credit Suisse | Outperform | $11.00 to $10.00 |
| 2015-03-02 | Downgrade | B. Riley | Buy to Neutral | $10.50 to $8.50 |
| 2014-12-07 | Reiterated Rating | B. Riley | Buy | $10.50 |
| 2014-12-03 | Reiterated Rating | Morgan Stanley | Equal Weight | $9.00 |
| 2014-12-03 | Boost Price Target | Credit Suisse | Outperform | $10.00 to $11.00 |
| 2014-11-29 | Reiterated Rating | B. Riley | Buy | $10.00 |
| 2014-09-04 | Boost Price Target | B. Riley | Buy | $10.00 |
| 2014-07-07 | Initiated Coverage | B. Riley | Buy | $9.75 |
| 2014-06-05 | Reiterated Rating | Credit Suisse | Outperform | $11.00 to $10.00 |
| 2014-06-05 | Lower Price Target | Pacific Crest | $17.00 to $12.00 | |
| 2014-05-22 | Lower Price Target | Goldman Sachs | $8.00 to $7.00 | |
| 2014-05-14 | Reiterated Rating | Deutsche Bank | Hold | $9.00 |
| 2014-01-22 | Reiterated Rating | Morgan Stanley | Equal Weight | |
| 2013-11-21 | Reiterated Rating | Deutsche Bank | Hold | $8.00 |
| 2013-02-22 | Reiterated | Deutsche Bank | Hold | $7.50 to $8 |
| 2013-01-11 | Downgrade | BMO Capital Markets | Outperform to Market Perform | $9 |
| 2012-11-27 | Reiterated | Deutsche Bank | Buy | $28 to $25 |
| 2012-04-04 | Initiated | Deutsche Bank | Buy | $26 |
| 2012-04-04 | Initiated | BMO Capital Markets | Outperform | $24 |
| 2016-06-10 | Reiterated Rating | Morgan Stanley | Hold | |
| 2016-06-06 | Reiterated Rating | B. Riley | Buy | $8.00 |
| 2016-06-04 | Reiterated Rating | Credit Suisse | Buy | |
| 2016-06-04 | Reiterated Rating | Deutsche Bank | Hold | |
| 2016-06-04 | Reiterated Rating | Credit Suisse Group AG | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In BV 108 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | 50.63M |
| Vanguard Group, Inc | 3.87M |
| BlackRock Inc. | 3.23M |
| MACQUARIE GROUP LTD | 3.19M |
| WELLINGTON MANAGEMENT CO LLP | 3.14M |
| BlackRock Fund Advisors | 2.70M |
| BERNZOTT CAPITAL ADVISORS | 2.58M |
| BAMCO INC /NY/ | 2.40M |
| COOKE & BIELER LP | 2.24M |
| BlackRock Institutional Trust Company, N.A. | 2.18M |
| DIMENSIONAL FUND ADVISORS LP | 1.82M |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 1.31M |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 0.89M |
| STATE STREET CORP | 0.87M |
| PEREGRINE CAPITAL MANAGEMENT INC /MN/ | 0.80M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Hurt Brett A. Founder, CEO & President | 4.51% (3522305) | BV / |
| Austin Eugene President | 1.26% (985453) | BV / |
| Ittycheria Dev | 0.40% (315119) | ATHN / BV / |
| Connery Kelly E. Chief Revenue Officer | 0.23% (177916) | BV / |
| Pearson Lisa Chief Marketing Officer | 0.16% (126073) | BV / |
| Keller Edward B. | 0.14% (105653) | BV / |
| Barksdale Bryan C. General Counsel and Secretary | 0.12% (95017) | BV / |
| CAREY SYDNEY | 0.12% (91768) | BV / PFPT / TIBX / |
| Cannon Marc Executive VP, Client Services | 0.10% (78616) | BV / |
| MCDOWELL MARY T | 0.09% (70646) | ADSK / BV / |
| Collins Stephen R. CFO; Chief Innovation Officer | 0.09% (66604) | BV / |
| BERKOWITZ STEVE | 0.08% (64226) | BV / MOVE / |
| Kopf Jared | 0.07% (54377) | BV / |
| PACITTI CHRISTOPHER A | 0.03% (25273) | BV / |
| Barbarosh Craig A. | 0.03% (20640) | BV / QSII / SBRA / |
| Brunner Heather J. Chief Operating Officer | 0.02% (13162) | BV / CPT / |
| Nelson Erin C Chief Marketing Officer | 0.01% (7929) | BV / |
UM